APHA co-founder and chair person, Yvette Raphael, recently sat down with SciDev.net for a Q&A session where she emphaised the importance of inclusion of pregnant women and young girls in HIV trials, as well as healthcare and drug distribution programmes.

Today, Advocates for the Prevention of HIV in Africa (APHA) celebrates an extraordinary milestone as our co-founder and Executive Director, Yvette Raphael, receives the prestigious Mani L. Bhaumik Breakthrough of the Year Award for her pivotal role in advancing HIV prevention through the development and testing of Lenacapavir.

Yvette Raphael, co-founder and Executive Director at Apha, has been named as one of the three recipients of the Mani L. Bhaumik...

For decades, Africa’s HIV response has been heavily influenced by external donors and international health organisations. While these...

The fight against HIV has seen remarkable progress over the past two decades, with global initiatives like the U.S. President’s Emergency...

Watch Now

Image Source: Bhekisisa Pre-exposure prophylaxis (PrEP) is a preventive strategy involving a daily pill that combines two antiretroviral...

Image Source: Bhekisisa Yvette Raphael, a South African HIV activist diagnosed in 2000, has transformed her personal journey into a...

Source: Mail&Guardian Yvette Raphael, founder of Apha, sat down with the Bhekisisa Team at Mail&Guardian to discuss the implications of...